Vir Biotechnology, Inc.
S&P 600
$10.62
+0.38%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Current assets comfortably cover current liabilities (current ratio 5.54).
!Watch-points
- Return on equity is on the lower side at -44.6%.
- Return on capital employed is on the lower side at -42.7%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
1.04
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Piotroski F-ScoreWeak
3 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$1.80B
Current Price$ 10.62
High / Low$ 11.94 / 4.75
Stock P/E-3.36
Book Value$ 5.82
Dividend Yield0%
ROCE-42.72%
ROE-44.58%
Current Ratio5.54
P/B Ratio2.106725
EPS$ -3.16
PAT Margin-638.87%
Cash PAT$-426.31M